Trial
NCT06420908
Adebrelimab Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Hebei Medical University Fourth Hospital
Collaborators
—
Condition
Esophageal Squamous Cell Carcinoma
Intervention
Adebrelimab+TP/FP+ radiation therapy
Why stopped
The primary reason for termination was difficulty in recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-26